ENT indications for hyperbaric oxygen therapy
P. Germonpre , P. Levie , C. Dehalleux and D. Caers
Centre for Hyperbaric Oxygen Therapy, Military Hospital Brussels, Belgium; Department of Otorhinolaryngology and Head & Neck Surgery, St-Anne St-Remi Hospital (Chirec Group), Brussels, Belgium; Department of Otorhinolaryngology and Head & Neck Surgery, Edith Cavell Hospital (Chirec Group), Brussels, Belgium
Hyperbaric oxygen therapy; HBO; osteoradionecrosis; inner ear decompression sickness; anaerobic infection; compromised flaps and grafts
87 - 106
ENT indications for Hyperbaric Oxygen Therapy. Hyperbaric Oxygen (HBO) therapy is a treatment where patients breathe 100% oxygen while exposed to high environmental pressure in a hyperbaric chamber. This hyperoxygenation has several beneficial effects as an adjunctive treatment in a number of ENT-related conditions and diseases. These can be summarized as anti-ischaemic effects (delivery of oxygen to otherwise ischaemic tissues, reduction of ischaemia-reperfusion damage), anti-infectious effects (bacteriostasis, improved leucocyte phagocytosis bactericidal activity and optimization of antibiotic therapy) and wound-healing effects (stimulation of granulation tissue formation and stabilization). Since HBO therapy has a clear physiologic rationale, a demonstrated effect (although difficult to “prove” with placebo- controlled randomized trials) in certain indications and certain side-effects, it is proposed that it should be considered an integral part of the (combined surgical and pharmacological) treatment of patients, and not simply as a supplementation of oxygen. Furthermore, the importance of a well-trained medical and technical staff to ensure proper selection and the correct follow-up of patients should not be underestimated.
Suppl. 26.1, 2016

ENT indications for hyperbaric oxygen therapy